Fierce Pharma February 3, 2023
By Max Bayer, Fraiser Kansteiner

J&J’s pharmaceutical changes come as the company spins off its consumer healthcare group into a separate company called Kenvue. (BSR Agency/Getty Images News)

Three Johnson & Johnson pharmaceutical executives stood before a group of staff in the R&D unit Wednesday, joking about expensive Uber rides and one “phenomenal dinner” at a Japanese steakhouse while attending the J.P. Morgan Healthcare Conference in San Francisco in early January.

But just minutes earlier, the mood was anything but jovial, as the leaders explained to a nervous group of employees in the Janssen pharmaceutical unit an overhaul of operations for the infectious diseases and vaccine groups, with sweeping layoffs expected to claim staffers’ jobs in countries around the world. Some staff...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries
Americans split on using weight loss drugs to treat obesity: Survey
ASHP to CMS: 'Change course' on drug pricing
New AI model predicts gene expression across human cell types
Most Ditch GLP-1 Drugs for Weight Loss Within a Year

Share This Article